Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
Study NCT ID:
NCT01359956
Status:
COMPLETED
Last Update Posted:
2023-04-11
First Post:
2011-05-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma
Sponsor:
National Cancer Institute, Naples
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-04
Start Date Type:
None
Primary Completion Date:
2011-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-13
First Submit QC Date:
None
Study First Post Date:
2011-05-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-09
Results First Submit QC Date:
None
Results First Post Date:
2020-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-15
Last Update Post Date:
2023-04-11
Last Update Post Date Type:
ACTUAL